Literature DB >> 7036814

The medical management of primary hyperparathyroidism.

J P Bilezikian.   

Abstract

Primary hyperparathyroidism has become a relatively common endocrine disorder. Greater recognition of this disease has led to earlier detection. Consequently, primary hyperparathyroidism is now characterized frequently by asymptomatic mild hypercalcemia rather than by the more classical presentation with bone or renal involvement. Patients who have hypercalcemia and signs or symptoms should undergo neck surgery and removal of the abnormal parathyroid tissue. For the growing population of asymptomatic patients, however, indications for surgery are not as clear. The natural history of primary hyperparathyroidism is variable, and predicting who will develop complications of this disorder is not possible. Alternatives to surgery are careful and regular observation combined with various general and specific approaches currently receiving attention. Available information on the medical management of asymptomatic, mild primary hyperparathyroidism is summarized.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7036814     DOI: 10.7326/0003-4819-96-2-198

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  8 in total

1.  Long term follow up of untreated primary hyperparathyroidism.

Authors:  C Nagant de Deuxchaisnes; J P Devogelaer; J P Huaux
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-05

2.  Intestinal "bioavailability" of solutes and water: we know how but not why.

Authors:  A N Charney
Journal:  Yale J Biol Med       Date:  1996 Jul-Aug

3.  Long term follow up of untreated primary hyperparathyroidism.

Authors:  C R Paterson; J Burns; E Mowat
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10

4.  Acute complications in the course of "mild" hyperparathyroidism.

Authors:  S M Corsello; G Folli; F Crucitti; S Della Casa; C A Rota; A Tofani; S Colasanti; A Barbarino
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

5.  Parathyroid adenomectomy under local anesthesia with intra-operative monitoring of UcAMP and/or 1-84 PTH.

Authors:  Y Chapuis; P Icard; Y Fulla; L Nonnenmacher; P Bonnichon; A Louvel; B Richard
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

6.  The influence of surgery on the risk of death in patients with primary hyperparathyroidism.

Authors:  G Hedbäck; A Odén; L E Tisell
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

7.  Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent.

Authors:  S Hirschel-Scholz; J Caverzasio; J P Bonjour
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

Review 8.  Primary hyperparathyroidism in younger and older patients: symptoms and outcome of surgery.

Authors:  P Udén; A Chan; Q Y Duh; A Siperstein; O H Clark
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.